In this retrospective cohort study, insulin use in people with T2DM and compensated cirrhosis was associated with higher risks of hypoglycemia, cardiovascular events, liver-related complications, and mortality than insulin nonusers. This evidence concerns the gene INS and type 2 diabetes mellitus.